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ABSTRACT
INTRODUCTION Smokeless tobacco (ST) remains poorly regulated in Bangladesh. 
This study describes the prevalence and trends of ST use in Bangladesh, 
presents ST-related disease burden, identifies relevant policy gaps, and 
highlights key implications for future policy and practice for effective ST 
control in Bangladesh.
METHODS We analyzed secondary data from the two rounds (2009 and 2017) 
of The Global Adult Tobacco Survey, estimated ST-related disease burden, 
and conducted a review to assess differences in combustible tobacco and ST 
policies. In addition, we gathered views in a workshop with key stakeholders 
in the country on gaps in existing tobacco control policies for ST control in 
Bangladesh and identified policy priorities using an online survey.
RESULTS Smokeless tobacco use, constituting more than half of all tobacco 
use in Bangladesh, declined from 27.2% (25.9 million) in 2009 to 20.6% 
(22 million) in 2017. However, in 2017, at least 16947 lives and 403460 
Disability-Adjusted Life Years (DALYs) were lost across Bangladesh due to 
ST use compared to 12511 deaths and 324020 DALYs lost in 2010. Policy 
priorities identified for ST control have included: introducing specific 
taxes and increasing the present ad valorem tax level, increasing the health 
development surcharge, designing and implementing a tax tracking and 
tracing system, standardizing ST packaging, integrating ST cessation within 
existing health systems, comprehensive media campaigns, and licensing of 
ST manufactures. 
CONCLUSIONS Our analysis shows that compared to combustible tobacco, there 
remain gaps in implementing and compliance with ST control policies in 
Bangladesh. Thus, contrary to the decline in ST use and the usual time lag 
between tobacco exposure and the development of cancers, the ST-related 
disease burden is still on the rise in Bangladesh. Strengthening ST control 
at this stage can accelerate this decline and reduce ST related morbidity and 
mortality.
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A diverse range of smokeless tobacco (ST) products 
are used worldwide. The pattern of ST consumption 
varies across countries due to differing socio-cultural 
norms, price, availability, accessibility, and tobacco 
control policies1. Betel quid with tobacco, zarda, gul, 
naswar, gutkha, and khaini are popular in South and 
South-East Asia. At the same time, the most commonly 
used ST products in other parts of the world include 
snus (Nordic countries and North America), chimó 
(Venezuela), nass (Kyrgyzstan, Uzbekistan), tambook 
(Chad, Sudan), and snuff (Ghana, Nigeria, South 
Africa)2. ST products are highly addictive, which 
results in high nicotine concentration and absorption. 
All ST products consumed in South and South-East 
Asia also contain carcinogenic substances like tobacco-
specific N-nitrosamines (TSNAs). Many ST products 
are linked to wide-ranging harms, including specific 
types of cancers (head and neck), cardiovascular 
diseases, and poor perinatal outcomes3. ST use leads 
to an increased risk of cancers of the oral cavity, 
pharynx, and esophagus and increased deaths due to 
cardiovascular diseases4,5. Moreover, ST consumption 
during pregnancy is associated with low birth weight 
and stillbirths6.
The prevalence of ST use is high in Bangladesh. 
It ranks second in the world among high ST burden 
countries7, with 22 million (20.6%) adults consuming 
at least one form of ST product regularly8. Among 
adolescents aged 13–15 years, current ST use is 4.5%, 
with estimates of 5.9% and 2.0% in boys and girls, 
respectively9. Thus, ST use is higher than combustible 
tobacco use among adults8 and adolescents9 in 
Bangladesh. 
ST products are popular, affordable, and readily 
available in Bangladesh, and their use is socially 
acceptable, also among women and young people1,5. 
However, low price, availability, and misconceptions 
regarding its beneficial health effects contribute to 
high ST use in Bangladesh1,10.
Bangladesh is a signatory to the World Health 
Organization (WHO) Framework Convention for 
Tobacco Control (FCTC). However, less attention 
has been paid to ST control compared to combustible 
tobacco1. With funding from the National Institute 
for Health Research (NIHR), UK, a group has 
been established by several academics, civil society 
organizations, and statutory bodies to address ST 
use in South Asia, including Bangladesh. The group 
is called ASTRA – Addressing Smokeless Tobacco 
and Building Research Capacity in South Asia11. 
On behalf of ASTRA, a mixed-methods study was 
conducted to describe ST prevalence and trend, 
estimate disease burden, and identify policy gaps, 
opportunities, and priorities to improve ST control 
in Bangladesh.
METHODS
Our methodology involved five steps where we: 
1) analyzed secondary data from two rounds of 
the Global Adult Tobacco Survey, 2009 and 2017 
(GATS); 2) estimated the burden of disease due to 
ST consumption in adults and compared it with a 
2010 estimate; 3) conducted a desk review of current 
tobacco control policies; 4) arranged an interactive 
workshop during the last quarter of 2019 to gather 
stakeholders’ views on gaps in the implementation of 
existing tobacco control policies for ST control; and 
5) identified policy priorities using an online survey 
at the same period. 
Secondary data analysis
Data were analyzed from the GATS 2009 and 2017 
to compare tobacco (total and prevalence) and ST 
consumption (total and prevalence) between the 
two rounds and compared ST use distribution with 
combustible tobacco.
 
Estimating the disease burden
As part of estimating the global burden of ST use in 
127 countries12, data were extracted for Bangladesh 
to calculate the disease burden due to ST use among 
adults. First, the country-specific prevalence of ST 
use in both men and women in Bangladesh was 
identified. Then, using the prevalence estimates 
and known disease risk (relative risks/odds ratios) 
estimates for oral, pharyngeal, and esophageal 
cancers and cardiovascular diseases12, the population 
attributable fraction (PAF) was estimated for ST 
use for Bangladesh. PAF would be the proportional 
reduction in disease or mortality if exposure were 
reduced to zero13,14. PAF was estimated for each 
disease for each country for both males and females, 
using the following formula:
PAF=Pe (RRe–1)/[1 + Pe (RRe–1)]
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where Pe=prevalence of smokeless tobacco uses in 
that population and RRe=relative risk of disease (e.g. 
mouth cancer) due to SLT use.
Finally, these PAFs were used to estimate the 
disease burden attributable to ST for Bangladesh as 
a proportion of the deaths reported in the 2017 Global 
Burden of Disease study and Disability-Adjusted 
Life Years (DALYs) lost. Finally, the findings were 
compared with similar estimates using 2010 data 
reported by Siddiqi et al.2. 
Desk review
A desk review was carried out to assess differences 
in combustible tobacco and ST policies, if any. For 
this purpose, we reviewed tobacco-related policies, 
bills, acts, and legislative documents, and Statutory 
Regulatory Orders (SROs) issued in the last 15 
years (2005–2019) by the Bangladesh Ministry of 
Health and Family Welfare (MOHFW) and Ministry 
of Finance. The documents had been collected from 
the National Tobacco Control Cell (NTCC) and Non-
Communicable Disease Control Program (NCDC), 
MOHFW. In addition, two ministries’ websites (www.
mof.gov.bd; www.mohfw.gov.bd) were also searched 
to extract relevant information. 
Priority setting workshop
We shared the findings of the above three methods 
of work at a stakeholders’ workshop. While the 
workshop’s primary aim was to share and validate the 
emerging results of desk review and secondary data 
analyses with the key stakeholders, the discussions 
during the workshop were expected to provide 
valuable data to identify the gaps in implementing 
tobacco control policies for ST control. Out of 44 
invitees, a total of 38 policymakers, academics, 
advocates, and media representatives attended. The 
discussions were organized around five themes: fiscal 
policies, product regulation, education and awareness, 
cessation support, and knowledge gaps. We validated 
the policy gaps identified through the desk review 
with the experience and views of the participants in 
the workshop. Finally, we presented the data to and 
recorded comments of the participants, which were 
later triangulated with the findings from the desk 
review and the survey. A total of 44 key stakeholders 
were invited who are working in tobacco control 
in Bangladesh. The discussion was audio-recorded 
with the participants’ prior written consent, and two 
researchers took detailed notes. Consultations were 
analyzed thematically to identify key priorities for and 
challenges and opportunities in addressing ST use in 
Bangladesh. 
Online survey
Post-workshop, all 38 stakeholders were invited to 
complete an online survey to rank the policy options 
on a 5-point scale regarding their priority level. 
Stakeholder’s responses (n=36) were analyzed, and 




The two rounds of GATS indicated a decline in 
tobacco use among adults aged ≥15 years from 43.3% 
in 2009 to 35.3% in 2017, reflecting an 18.5% relative 
decline (Table 1). The absolute number of regular 
tobacco users also decreased over the period, from 
41.3 million in 200915 to 37.8 million in 20178. 
Combustible tobacco and ST use 
ST use among adults (aged ≥15 years) declined 
from 27.2% in 2009 to 20.6% in 2017. In 2009, 25.9 
million adults used ST, which represented 62.7% of 
Table 1. Percentage of tobacco use by gender (GATS, 
2009 and 2017)




Overall Overall tobacco use 43.3 35.3 -18.5
Among males 58.0 46.0 -20.7
Among females           28.7 25.2 -12.2
Combustible 
(cigarette)
Overall cigarette use 14.2 14.0 -1.4
Among males 28.3 28.7 1.4
Among females                0.2 0.2 0.0
Combustible 
(bidi)
Overall bidi use 11.2 4.8 -57.1
Among males 21.4 9.7 -54.7
Among females 1.1 0.6 -45.5
Smokeless 
(any)
Overall ST use 27.2 20.6 -24.3
Among males 26.4 16.2 -38.6
Among females 27.9 24.8 -11.1
*Percent change is estimated as (t1-t2)/t1, where t1 is the base value in year 2009 and t2 
is the value in 2017.
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all tobacco users, while in 2017, over 22 million adults 
used ST regularly, which constituted more than half 
(58.0%) of all tobacco users16. Among overall tobacco 
users, 18.7% were using betel quid with tobacco, and 
3.6% were using gul in 201716. 
The extent of change in tobacco use over time 
varied by cigarette, bidi, ST products, and gender 
(Table 1). Overall combustible tobacco use declined 
from 23.0% in 2009 to 18.0% in 2017, while ST 
consumption over the same period decreased from 
27.2% to 20.0%. ST use exceeded the prevalence of 
combustible tobacco use among adults in 200915, and 
the pattern remained the same in 2017.
While bidi and ST use had declined, specifically 
among men, cigarette use has remained the same from 
2009 to 201715. Combustible tobacco use among men 
and ST use among women was still very high in 2017. 
Disease burden due to ST use
Contrary to the decline in ST use and in line with 
the usual time lag between tobacco exposure and 
the development of cancers, the ST-related disease 
burden is still on the rise. Using GATS 2009 data, 
Siddiqi et al.2 estimated that 12511 deaths and 
324020 DALYs were lost in Bangladesh due to ST-
related diseases. Data extracted from the estimation 
of the global disease burden12 suggests that in 2017, 
at least 16947 lives and 403460 DALYs were lost 
across Bangladesh due to oral, pharyngeal, esophageal 
cancers, and ischemic heart diseases that can be 
attributed to ST. Disease-specific DALYs and deaths 
that are attributed to ST use are shown in Figure 1. 
Tobacco control policies and gaps in ST control
Smoking and Tobacco Product Usage Act in 2005 
only covered combustible tobacco. The definition 
of ‘tobacco’ did not include ST as a tobacco product 
until 2013; the Act was not applicable for ST control 
(Figure 2). The Act was amended in 2013, and the 
Smoking and Tobacco Product Usage rules have been 
passed in 2015, which now covers both combustible 
tobacco and ST products1. A comparison of the 
tobacco control laws in Bangladesh for combustible 
tobacco and ST are summarized in Table 2. Almost 
all tobacco control laws apply to both combustible 
and ST products, except smoke-free laws. There is 
no law to prohibit the quantity of sale of any tobacco 
product. ST can be sold in any amount and is available 
Figure 1. Burden of diseases due to ST use in Bangladesh (deaths per year, DALYs lost per year)
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in different-sized packs. This also restricts the law’s 
implementation of pack warning and banderols; 
warning labels and banderols cannot be added to 
small-sized ST packs, such as 5 g and 10 g packs. 
Tobacco packs – both combustible and ST – are not 
required to contain information on nicotine and tar 
content by law. Neither do the manufacturers are 
obliged to disclose the contents to the appropriate 
authorities. 
Barriers and opportunities
Most of the participants in the stakeholders’ 
workshop acknowledged that despite the continuous 
government commitment for tobacco control, there 
remain gaps in implementation of and compliance to 
ST policies and regulations, requiring policymakers’ 
attention to reduce ST-related disease and economic 
burden in Bangladesh. Participants noted that ST 
was ingrained within Bangladeshi culture; hence 
awareness programs would likely only be effective 
if strictly enforced policies and regulations for ST 
control were in place. The large informal sector 
of ST manufacturing, storage, and distribution 
in Bangladesh makes it challenging to carry out 
product regulation through licensing and taxation. 
Other barriers to implementing policies against ST 
include a lack of governmental prioritization for ST 
control, the diverse nature of the ST, variations in the 
packaging, the complex supply chain with a limited 
understanding of the actors and their relationships, a 
lack of awareness of the ST-related health risks among 
policymakers and legislators, non-coordination among 
different ministries and departments, and an absence 
of evidence on cessation strategies. It was argued that 
obtaining information about the ingredients used 
in ST products and the date of manufacture is the 
people’s right, which may encourage users to quit 
ST use for a healthy life. It was also suggested that 
manufacturers notify the government about the levels 
of nitrosamines and tar they use in ST products. A 
multi-sectoral approach must coordinate decision-
makers within different ministries, tobacco control 
advocates, and wider stakeholder groups. 
Policy priorities
The following priorities were identified (and ranked 
by the 36 workshop participants):
Fiscal policies
In all, 83% suggested imposing a specific tax on 
ST products as the most important fiscal measure 
to regulate ST products. A large proportion of 
participants (73%) also suggested increasing the 
current tax level for ST products, especially increasing 
the current health development surcharge on all 
tobacco products’ retail prices, either manufactured 
or imported (67%), as a priority. Designing and 
implementing a tax tracking and tracing system for 
ST (61%) should also be considered the government’s 
highest priority. Participants also suggested 
earmarking the tobacco taxes generated through the 
health development surcharge on tobacco products to 
provide alternative livelihoods to tobacco cultivators 
and laborers by ensuring the proper use of the budget 
Table 2. A comparative analysis of tobacco control laws in Bangladesh for both combustible tobacco and 
smokeless tobacco 
Sections under Smoking and Tobacco Product Usage Act 2005 Combustible Smokeless 
tobacco
Requirements to have nicotine and tar contents on the label produced locally No No
Requirements to have excise stamp, affixing banderols on the pack Yes Yes
Prohibition on quantity, i.e. sale less than 20 per pack No No
Smoke-free laws Yes Not applicable
Pictorial health warning on packs Yes Yes
Restriction on advertisement of tobacco Yes Yes
Restriction of promotion of samples Yes Yes
Prohibition of sale of tobacco to minors and by minors Yes Yes
Prohibition of storage, sale and distribution of tobacco in the immediate vicinity of educational institutions No No
Restriction on use in a public place and public transport Yes No
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from the 1% health development surcharge. 
Cessation services
About two-thirds of the participants (61%) considered 
integrating treatment for tobacco dependence within 
the existing health systems as a very high priority. 
In addition, a national guideline for treating tobacco 
dependence, including smokeless tobacco (56%), 
comprehensive services to treat tobacco dependence 
(cessation clinics, quitlines) (53%), and incorporating 
treatment of tobacco dependence in health 
professionals’ curriculum (50%) were also considered 
highly important to reduce ST use.
Education and awareness
High priority for ST control was given to 
comprehensive media campaigns to raise public 
awareness (86%). Half of the participants suggested 
that anti-tobacco messages must be included within 
educational institutions and their curriculum. 
However, as a strong network of tobacco control 
advocates is already in place, only 44% of participants 
thought that an anti-tobacco advocacy coalition 
consisting of legislators, health professionals, 
journalists, cancer charities, and patient support 
groups was mandatory to control ST in the country.
Product regulation
Almost all agreed that formalizing the ST industry 
(e.g. licensing manufacturers, suppliers, and 
vendors) needed to be highly prioritized to control 
ST (89%). The formalization should be followed 
by the government formulating necessary policy 
to discourage the production and usage of ST and 
related crops (86%) and standardizing ST packaging 
and labelling, including pictorial warnings (81%). 
More than two-thirds of the participants pointed 
out that manufacturers must be obligated to list and 
disclose all ingredients to relevant authorities (70%).
Research priorities
The most important research priorities were 
identifying points in the ST supply chain where taxes 
can be levied (64%) and estimating the economic 
burden of ST in the country (53%). In addition, half of 
the participants thought it would be ideal to establish 
a technical group of experts to support the country’s 
national tobacco control cell. A few participants also 
emphasized the importance of assessing potential 
interventions to address ST use in different contexts.
DISCUSSION
While ST use among adults declined between 2009 
and 2017 in Bangladesh, there has been a considerable 
rise in ST-related morbidity and mortality over the 
same period. We found that Bangladesh has made 
notable progress in adopting ST control policies, 
including levying taxes on ST retail price, introducing 
pictorial health warnings, and banning advertising. 
However, implementation of and compliance with 
ST control policies are weak compared to regulatory 
efforts for combustible tobacco products. Moreover, 
most policies cannot be implemented adequately to 
address ST, mainly due to their diverse nature and 
manufacturing in informal settings. This implies that 
ST control policies and their implementation need 
to be strengthened. This priority setting exercise 
provided a list of policy actions to address ST use 
in Bangladesh, including introducing specific taxes 
and increasing the present ad valorem tax level for 
ST, especially increasing the health development 
surcharge, standardizing ST packaging, integration 
of ST cessation within existing health systems, 
comprehensive media campaigns, and an introduction 
of licensing of ST manufactures.
Taxation on ST remains low in Bangladesh 
compared to cigarettes. According to the budget 
speech presented in the Bangladesh National 
Parliament in 2020, in the fiscal year (FY) 2021, the 
supplementary duty (SD) of cigarettes for low-tier 
and three other tiers is 57% and 65% of maximum 
retail price (MRP), respectively, while the SD is 55% 
of MRP for zarda and gul. Imposing specific tax along 
with considerable increases in current ad valorem tax 
(supplementary duty) and price increase of all types 
of tobacco products to ensure that the affordability 
of heterogeneous ST products continues to decline 
was considered as a priority. Tax increases should 
be comparable across all tobacco products to reduce 
opportunities for substitution in response to changes 
in relative prices17,18. The government changed the tax 
base for zarda and gul from ex-factory price to MRP 
in FY 2020 and increased the price of a 10 g pack of 
zarda and of gul from 12 Taka (about US$0.14) and 6 
Taka in FY 201919 to 40 Taka and 20 Taka in FY 2021, 
respectively. However, this price increase will not 
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impact ST consumption as many ST manufacturers 
are not registered and therefore not paying taxes 
and VAT to the government1. ST manufacturing 
units need to be formalized by bringing them under 
the licensing and registration process. This will also 
increase the tax revenue as ST taxation contributes 
only 0.22% of the tobacco tax revenue collected by 
the National Board of Revenue in Bangladesh16. Also, 
several non-manufactured ST products are available 
in the open market, which remain outside the tax net. 
In addition to affixing banderols on ST products, 
designing and implementing an effective tax tracking 
and tracing system has been identified as a priority to 
monitor the real-time movement of the ST products 
through all stages of the supply chain and verify 
tax payments. Track and trace systems have been 
successfully used in Moldova, Turkey, and Brazil to 
increase tax collection, create new legal businesses, 
decrease tobacco use and improve public health20,21. 
Pictorial health warnings need to be enforced for all 
types of products. This may require the standardization 
of ST packs to ensure compliance with the current 
law of 50% pack warning. Despite a high disease 
burden associated with ST use, cessation services are 
not available for ST users in routine healthcare at 
public facilities in Bangladesh1 and integrated policy 
including cessation support is warranted22. Also, as 
per the participants in the present study, a dearth 
of research on effective contextual intervention and 
lack of evidence on supply chain control remain to be 
addressed in the country, and matches the findings of 
a recent study23. The same study also suggests that the 
implementation of FCTC has not been in alignment 
with the requirements of ST control policies and vice 
versa. 
The two rounds of GATS highlighted both a sharp 
decline in bidi use and a considerable reduction in ST 
use in Bangladesh over the last ten years. However, 
cigarettes, which remain a more expensive form of 
tobacco, remained the same over the years. This 
indicates that sustained growth of the market of cheap 
cigarettes and inappropriate tobacco tax structure 
combined with socioeconomic development might 
have resulted in brand and product switching rather 
than reducing or quitting tobacco use when taxes and 
prices increase24,25. 
Previous studies also suggested that the ST-related 
disease burden is substantial, with at least 2.5 million 
DALYs lost in 201712. However, efforts to control 
ST use, in general, remain suboptimal compared 
to cigarette consumption26. The policy priorities 
identified in our analysis are consistent with global 
priorities for ST control3,27. Further research is needed 
to assess the impact of these policies and interventions 
on health. We recommend a multi-sectoral approach 
and a comprehensive media campaign to address 
public health issues like ST. 
Limitations
Our study has several limitations. First, a selected 
number of participants were invited for the 
workshop and the online survey, who had been 
purposively chosen from the wider stakeholder 
group (health advocates, healthcare providers, media 
representatives, and researchers) working on tobacco 
control. However, the stakeholders had long working 
experience in the field, and many of them had closely 
worked with the policymakers in developing tobacco 
control policies in Bangladesh. Second, the GATS 
2017 full data set was not available during the study 
period, which restricted further analysis of the data. 
Despite the limitations, this paper is the first attempt 
to consolidate and coordinate research and advocacy 
expertise in ST use in Bangladesh and identified 
policy priorities for ST control in Bangladesh. 
CONCLUSIONS
Smokeless tobacco consumption has declined in 
Bangladesh since 2009, and strengthening ST control 
at this stage can accelerate this decline and reduce ST-
related morbidity and mortality, including oral cancer 
deaths, over the coming decades. Strict enforcement 
of the law, stringent tax measures, and cessation 
support need to be provided by strengthening the 
tobacco control program. 
REFERENCES 
1. Huque R ,  Zaman MM,  Huq SM,  S inha  DN. 
Smokeless tobacco and public health in Bangladesh. 
Indian J Public Health. 2017;61(Suppl 1):S18. 
doi:10.4103/ijph.IJPH_233_17
2. Siddiqi K, Shah S, Abbas SM, et al. Global burden of 
disease due to smokeless tobacco consumption in 
adults: analysis of data from 113 countries. BMC Med. 
2015;13:194. doi:10.1186/s12916-015-0424-2
3. Siddiqi K, Islam Z, Khan Z, et al. Identification of Policy 
Priorities to Address the Burden of Smokeless Tobacco 
Research Paper
Tobacco Induced Diseases 
Tob. Induc. Dis. 2021;19(October):78
https://doi.org/10.18332/tid/140826
9
in Pakistan: A Multimethod Analysis. Nicotine Tob Res. 
2019;22(12):2262-2265. doi:10.1093/ntr/ntz163
4. Boffetta P, Hecht S, Gray N, Gupta P, Straif K. Smokeless 
tobacco and cancer. Lancet Oncol. 2008;9(7):667-675. 
doi:10.1016/S1470-2045(08)70173-6
5. Zaman MM, Ahmed J, Choudhury SR, Numan SM, 
Parvin K, Islam MS. Prevalence of ischemic heart disease 
in a rural population of Bangladesh. Indian Heart J. 
2007;59(3):239-241. Accessed April 4, 2021. https://
pubmed.ncbi.nlm.nih.gov/19124932/
6. Inamdar AS, Croucher RE, Chokhandre MK, Mashyakhy 
MH, Marinho VC. Maternal Smokeless Tobacco Use in 
Pregnancy and Adverse Health Outcomes in Newborns: A 
Systematic Review. Nicotine Tob Res. 2015;17(9):1058-
1066. doi:10.1093/ntr/ntu255
7. Sinha DN, Gupta PC, Kumar A, et al. The Poorest of Poor 
Suffer the Greatest Burden From Smokeless Tobacco 
Use: A Study From 140 Countries. Nicotine Tob Res. 
2018;20(12):1529-1532. doi:10.1093/ntr/ntx276
8. Bangladesh Bureau of Statistics, World Health 
Organization, Centers for Disease Control and Prevention. 
Global Adult Tobacco Survey: Bangladesh 2017. 




9. World Health Organization. WHO Report on the 
Global Tobacco Epidemic, 2013: Enforcing bans on 
tobacco advertising, promotion and sponsorship. 
World Health Organization; 2013. Accessed April 
11, 2021. https://apps.who.int/iris/bitstream/
handle/10665/85380/9789241505871_eng.pdf
10. Rahman MA, Mahmood MA, Spurrier N, Rahman 
M, Choudhury SR, Leeder S. Why do Bangladeshi 
people use smokeless tobacco products? Asia Pac 
J Public Health. 2015;27(2):NP2197-NP2209. 
doi:10.1177/1010539512446957
11. Readshaw A, Mehrotra R, Mishu M, et al. Addressing 
smokeless tobacco use and building research capacity in 
South Asia (ASTRA). J Glob Health. 2020;10(1):010327. 
doi:10.7189/jogh.10.010327
12. Siddiqi K, Husain S, Vidyasagaran A, Readshaw A, Mishu 
MP, Sheikh A. Global burden of disease due to smokeless 
tobacco consumption in adults: an updated analysis of 
data from 127 countries. BMC Med. 2020;18(1):222. 
doi:10.1186/s12916-020-01677-9
13. Rockhill B, Newman B, Weinberg C. Use and misuse of 
population attributable fractions. Am J Public Health. 
1998;88:15-19. doi:10.2105/AJPH.88.1.15
14. Oberg M, Jaakkola MS, Woodward A, Peruga A, Prüss-
Ustün A. Worldwide burden of disease from exposure 
to second-hand smoke: a retrospective analysis of data 
from 192 countries. Lancet. 2011;377(9760):139-146. 
doi:10.1016/S0140-6736(10)61388-8
15. Government of the People’s Republic of Bangladesh - 
Ministry of Health and Family Welfare, World Health 
Organization, Centers for Disease Control and Prevention. 
Global Adult Tobacco Survey: Bangladesh Report 2009. 
World Health Organization; 2009. Accessed April 11, 
2021. https://www.who.int/tobacco/surveillance/global_
adult_tobacco_survey_bangladesh_report_2009.pdf?ua
16. World Health Organization. WHO report on the global 
tobacco epidemic, 2017: Monitoring tobacco use and 
prevention policies. World Health Organization; 2017. 
Accessed April 11, 2021. https://apps.who.int/iris/
bitstream/handle/10665/255874/9789241512824-eng.
pdf?sequence=1
17. Nargis N, Hussain AK, Fong GT. Smokeless tobacco 
product prices and taxation in Bangladesh: findings from 
the International Tobacco Control Survey. Indian J Cancer. 
2014;51(0 1):S33. doi:10.4103/0019-509X.147452
18. Ahmed N, Mozumder TA, Hassan MT, Huque R. Demand 
for tobacco products in Bangladesh. Tob Control. 2021. 
doi:10.1136/tobaccocontrol-2020-056297
19. National Board of Revenue, Bangladesh. Annual Report 
2017-2018. Accessed April 11, 2021. https://www.nbr.
gov.bd/uploads/publications/2017-18_Vat_Saroni.pdf
20. Marquez PV, Guban I. What countries can learn from 
Moldova’s successful tobacco taxation efforts. World 
Bank Group; 2018. Accessed June 28, 2021. https://
blogs.worldbank.org/health/what-countries-can-learn-
moldova-s-successful-tobacco-taxation-efforts
21. Krasovsky K. Tobacco taxation policy in the Republic 
of Moldova. World Health Organization; 2016. Accessed 
April 11, 2021. https://www.euro.who.int/__data/assets/
pdf_file/0011/354692/Tobacco-taxation-policy-in-the-
Republic-of-Moldova.pdf
22. Siddiqui F, Croucher R, Ahmad F, et al. Smokeless 
tobacco initiation, use and cessation in South Asia: a 
qualitative assessment. Nicotine Tob Res. 2021:ntab065. 
doi:10.1093/ntr/ntab065
23. Naznin E, Wynne O, George J, et al. Smokeless tobacco 
policy in Bangladesh: A stakeholder study of compatibility 
with the World Health Organization's Framework 
Convention on Tobacco Control. Drug Alcohol Rev. 
2021;40(5):856-863. doi:10.1111/dar.13243
24. Ahmed N, Hossain J, Huque R, Hassan MT, Mozumder 
TA. The Economics of Tobacco Taxation in Bangladesh. 
Brac Institute of Governance and Development; 2019. 
Accessed April 11, 2021. https://bigd.bracu.ac.bd/wp-
content/uploads/2020/02/Report-The-Economics-of-
Tobacco-Taxation-in-BD-2019.pdf
25. Nargis N, Hussain AG, Goodchild M, Quah AC, Fong 
GT. A decade of cigarette taxation in Bangladesh: lessons 
learnt for tobacco control. Bull World Health Organ. 
2019;97:221. doi:10.2471/BLT.18.216135
26. Mehrotra R, Yadav A, Sinha DN, et al. Smokeless 
tobacco control in 180 countries across the globe: 
call to action for full implementation of WHO FCTC 
measures. Lancet Oncol. 2019;20(4):e208-e217. 
Research Paper
Tobacco Induced Diseases 




27. Yadav A, Singh PK, Yadav N, et al. Smokeless tobacco 
control in India: policy review and lessons for high-
burden countries. BMJ Glob Health. 2020;5:e002367. 
doi:10.1136/bmjgh-2020-002367
ACKNOWLEDGEMENTS
We are grateful to the participants of the workshop and the online 
survey for their valuable contribution. 
CONFLICTS OF INTEREST
The authors have each completed and submitted an ICMJE form for 
disclosure of potential conflicts of interest. The authors declare that 
they have no competing interests, financial or otherwise, related to 
the current work. J.S. Ahluwalia reports that a payment was made 
to his institution from National Institute of Health (NIH) in the past 
36 months. K. Siddiqi reports that a research grant was paid to his 
institution (University of York) since the initial planning of the work, 
from National Institute for Health Research, a public interest body.
FUNDING
This work was supported by the National Institute for Health Research 
(NIHR) by a Grant No. 17/63/76 to support a Global Health Research 
Group on Addressing Smokeless Tobacco and building Research capacity 
in south Asia (ASTRA). The authors alone are responsible for the views 
expressed in this article and do not necessarily represent the views, 
decisions or policies of the institutions with which the authors are 
affiliated.
ETHICAL APPROVAL AND INFORMED CONSENT
Ethical approval for the study was obtained from the Bangladesh 
Medical Research Council (BMRC/NREC/2016-2019/961, 7 January 
2019). Informed consent was not required as we analyzed secondary 
data from the Global Adult Tobacco Survey. Participants attending the 
study workshop and taking part in an online survey gave their written 
informed consent. 
DATA AVAILABILITY
The data supporting this research are available from the authors on 
reasonable request.
AUTHORS’ CONTRIBUTIONS
RH, ZAA, AS, SMA and KS conceptualized the study. ZAA collected the 
data. RH, ZAA, SMA and KS analyzed the data. RH and ZAA drafted 
the manuscript. All authors reviewed and approved the submitted 
manuscript.
PROVENANCE AND PEER REVIEW
Not commissioned; externally peer reviewed.
